UPDATED May 30, 2024
Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | kr63.00 | 5.7% | 25.0% | kr1.7b | kr86.00 | PE354.1x | E92.7% | 0% | ||
CRNA | kr3.19 | -61.5% | -77.9% | kr26.5m | kr12.00 | PS215.1x | E87.4% | n/a | ||
AZT | kr24.10 | -7.1% | -41.1% | kr1.2b | kr27.50 | PE69.8x | E48.5% | n/a | ||
NAVA | kr34.10 | -2.3% | -9.5% | kr594.5m | kr49.00 | PS1.2x | E39.7% | n/a | ||
ULTI | kr8.69 | 21.2% | -92.9% | kr299.0m | kr6.50 | PB1.2x | E28.5% | n/a | ||
ABS | kr10.40 | 2.0% | -2.3% | kr263.8m | kr10.00 | PS7.8x | E-6.0% | n/a | ||
NYKD | kr14.54 | -2.0% | -48.0% | kr4.7b | kr43.00 | PS40.9x | E-23.7% | n/a | ||
BGBIO | kr13.00 | 4.0% | -65.5% | kr508.1m | kr3,512.50 | PS975.3x | E-24.2% | n/a | ||
NANOV | kr2.00 | -18.3% | -22.2% | kr231.8m | n/a | PB3.6x | n/a | n/a | ||
SOFTX | kr0.09 | 0% | -98.6% | kr46.6m | n/a | PS6.7x | n/a | n/a | ||
TRMED | kr1.01 | -3.4% | n/a | kr237.7m | n/a | PB0.9x | n/a | n/a | ||
NORD | kr41.00 | 0% | n/a | kr203.8m | n/a | PE2x | n/a | 0% | ||
VISTN | kr22.80 | 1.8% | -6.2% | kr1.0b | n/a | PE18x | n/a | 4.4% | ||
EXTX | kr7.90 | 9.7% | -30.1% | kr253.4m | n/a | PS56849.8x | n/a | n/a | ||
HBC | kr2.07 | -3.7% | -31.9% | kr817.8m | n/a | PS3.6x | n/a | n/a | ||
PCIB | kr2.05 | 24.2% | 14.8% | kr76.5m | n/a | PS25.6x | n/a | n/a | ||
LYTIX | kr6.30 | 5.0% | -31.9% | kr312.5m | kr13.00 | PS78.3x | S108.1% | n/a |